Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
1. 系统已在2025-11-05 19:59:12对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2352-3026(24)00102-9
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2352302624001029
其他信息:
出版社: Elsevier BV
作者: Jehan Dupuis; Emmanuel Bachy; Franck Morschhauser; Guillaume Cartron; Noriko Fukuhara; Nicolas Daguindau; René-Olivier Casasnovas; Sylvia Snauwaert; Remy Gressin; Christopher P Fox; Francesco Annibale d’Amore; Philipp B Staber; Olivier Tournilhac; Krimo Bouabdallah; Catherine Thieblemont; Marc André; Shinya Rai; Daisuke Ennishi; Argyrios Gkasiamis; Mitsufumi Nishio; Luc-Matthieu Fornecker; Marie-Helene Delfau-Larue; Nouhoum Sako; Sebastien Mule; Laurence de Leval; Philippe Gaulard; Kunihiro Tsukasaki; François Lemonnier
